As AI reshapes how work gets done across industries, all organizations including life sciences are being challenged to balance speed, scale, and innovation with something equally critical: trust.
Faruk Capan, Chief Innovation Officer at EVERSANA, explores why human expertise must remain central to how AI is applied in healthcare not as a safeguard, but as a strategic driver.
Read Faruk Capan’s full perspective in MM+M – Medical Marketing and Media
Beyond Automation: Rethinking the Role of Humans in AI
Much of today’s AI conversation focuses on automation and how technology can replace tasks and accelerate workflows. But healthcare is different. Decisions here directly impact patient outcomes. And that approach falls short.
Human involvement in AI is not simply about oversight. It’s about embedding expertise across every stage of the process.
What are the Risks of AI in Healthcare Without Human Oversight?
Healthcare operates under a unique set of constraints. Scientific accuracy, regulatory alignment, and ethical responsibility are non-negotiable.
While AI brings speed and analytical power, speed without judgment introduces risk. The most effective applications of AI are not fully autonomous but designed to combine technology with human context, insight, and accountability.
The Power of a True Human‑in‑the‑Loop Model
A true human‑in‑the‑loop model ensures that expertise is integrated throughout AI‑enabled workflows, not added as a final checkpoint.
This approach allows organizations to:
- Maintain compliance while accelerating execution
- Improve the quality and relevance of communications
- Reduce delays in areas like medical, legal, and regulatory review
It also unlocks greater creative potential. As AI takes on repetitive tasks, teams can focus on higher‑value work and building stronger engagement and more meaningful experiences for patients and providers.
What’s Next for AI Adoption in Pharma?
As AI adoption accelerates, the organizations that succeed will be those that intentionally integrate human insight with machine capabilities.
By designing smarter workflows, companies can move faster, adapt in real time, and deliver more effective solutions for patients.
Learn more about EVERSANA’s human‑in‑the‑loop approach to AI
Women’s health is no longer a niche: it is a major, transformative category poised for long‑term growth. Now is the moment to build commercialization models that finally reflect its scale, importance and opportunity.
Explore how EVERSANA supports end‑to‑end commercialization models built for emerging and growth markets
Connect With An Expert!
Author
Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,500 employees globally that joined EVERSANA in December 2021. Faruk…